Harvard Bioscience Inc financial data

Symbol
HBIO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
84 October Hill Rd, Holliston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 202 % -13.3%
Quick Ratio 101 % -15%
Debt-to-equity 89.7 % -10.6%
Return On Equity -12 % -340%
Return On Assets -6.31 % -365%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.4M shares +2.94%
Common Stock, Shares, Outstanding 43.4M shares +2.92%
Entity Public Float 219M USD +54.7%
Common Stock, Value, Issued 434K USD -4.62%
Weighted Average Number of Shares Outstanding, Basic 43.4M shares +3.05%
Weighted Average Number of Shares Outstanding, Diluted 43.4M shares +1.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 107M USD -6.76%
Research and Development Expense 11.8M USD -2.12%
Selling and Marketing Expense 24M USD -1.23%
General and Administrative Expense 22.4M USD -8.54%
Operating Income (Loss) -2.13M USD -240%
Nonoperating Income (Expense) -6.11M USD -146%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.25M USD -764%
Income Tax Expense (Benefit) 484K USD -54.3%
Net Income (Loss) Attributable to Parent -8.73M USD -334%
Earnings Per Share, Basic -0.2 USD/shares -300%
Earnings Per Share, Diluted -0.2 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.26M USD +12.3%
Accounts Receivable, after Allowance for Credit Loss, Current 15.3M USD -13.7%
Inventory, Net 24.1M USD -10.1%
Other Assets, Current 4.45M USD +9.5%
Assets, Current 48.1M USD -8.2%
Deferred Income Tax Assets, Net 436K USD +30.9%
Property, Plant and Equipment, Net 4.49M USD +31.2%
Operating Lease, Right-of-Use Asset 4.36M USD -20.8%
Intangible Assets, Net (Excluding Goodwill) 14.7M USD -25.3%
Goodwill 56.7M USD +0.14%
Other Assets, Noncurrent 4.79M USD -39.7%
Assets 133M USD -8.53%
Accounts Payable, Current 6.04M USD +1.1%
Employee-related Liabilities, Current 3.22M USD +1.93%
Contract with Customer, Liability, Current 4.39M USD +6.48%
Liabilities, Current 25.7M USD +10.6%
Deferred Income Tax Liabilities, Net 772K USD +41.4%
Operating Lease, Liability, Noncurrent 4.56M USD -7.72%
Other Liabilities, Noncurrent 1.45M USD -0.07%
Liabilities 64.3M USD -9.67%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14.8M USD -0.81%
Retained Earnings (Accumulated Deficit) -150M USD -6.17%
Stockholders' Equity Attributable to Parent 68.8M USD -7.44%
Liabilities and Equity 133M USD -8.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.4M USD -22.6%
Net Cash Provided by (Used in) Financing Activities -1.06M USD +63.5%
Net Cash Provided by (Used in) Investing Activities -225K USD -178%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 43.4M shares +2.92%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28K USD +96.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 768K USD -34.5%
Deferred Tax Assets, Valuation Allowance 15.2M USD +4.94%
Deferred Tax Assets, Gross 22.5M USD -2.23%
Operating Lease, Liability 5.75M USD -18.6%
Depreciation 404K USD +21.3%
Payments to Acquire Property, Plant, and Equipment 645K USD +188%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.85M USD -48.9%
Lessee, Operating Lease, Liability, to be Paid 7.6M USD -20%
Property, Plant and Equipment, Gross 18.4M USD +0.85%
Operating Lease, Liability, Current 1.2M USD -43.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.07M USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD -27%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 228K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.85M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.06M USD -0.75%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 631K USD -24.4%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.22M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.06M USD +3.43%
Operating Lease, Payments 597K USD -8.58%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.47M USD -9.5%
Deferred Tax Assets, Net of Valuation Allowance 7.29M USD -14.4%
Share-based Payment Arrangement, Expense 5M USD +13.4%